Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | LIFE | NTB |
|---|---|---|
| Price | $36.13 | $58.56 |
| Change today | ▲ 5.89% | ▼ 0.34% |
| Market cap | $2.30B | $2.30B |
| Return, 3 months | +85.8% | -2.7% |
| Return, year to date | – | +20.7% |
| Return, 1 year | – | +43.9% |
| P/E (TTM) | -20.6 | 10.3 |
| P/B | 4.8 | 2.0 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | 3.42% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | -1.4% | +11.9% |
| Analyst buy share | 89% | 0% |
| RSI (14) | 53 | 45 |
| 30-day volatility | 64.0% | 14.4% |
| Max drawdown, 1 year | -50.1% | -9.5% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
